Biogen’s Post

The 2024 Death Valley Ride to Cure ALS 🚴♂️🌵 This October, whether on two wheels or from afar, you can make an impact in the fight against ALS. The Death Valley Ride to Cure ALS is more than a cycling challenge; it's a beacon of hope, resilience, and community in the beautiful expanse of Death Valley National Park. Why Your Participation Matters? Every stride and every donation brings us closer to defeating ALS, a disease that affects thousands worldwide. Your involvement funds crucial research and support, moving us towards a cure. Event Details: - Location: Death Valley National Park, CA - Date: April 9-17, 2024 -Register: As a team or individual Can't Ride [like myself]? Your Support Still Has Power: - Donate: Direct contributions fuel ongoing ALS research and aid. - Sponsor a Rider: Boost a participant's fundraising efforts and impact. - Spread the Word: Share our mission with your network and help amplify our cause.

It is always fun to bring an idea to full fruition.

What makes philanthropy essential to us? In my opinion, the need to eradicate societal problems and bring forth beneficial changes in people's lives. What do we envision at Mankind Pharma? Supporting the 'act of giving' through CSR associations, sustainable activities, and—above all—active community engagement.    In my recent conversation with TheCSRUniverse, I got an opportunity to enlighten MANKIND PHARMA LTD’s philanthropic objectives and endeavours. As we remain dedicated to leaving a long-lasting legacy of compassion, we constantly navigate the evolving field of CSR. #interview #csr #society #philanthropy

Last week was our 7th Annual BIG GIVE and we went LIVE each day and dove into the topics of our Learn - Treat - Cure initiative for our science and research strategy. In one segment, we were joined by Carrie Howell, Executive Director of Dup15q Alliance, and Jackie Vanderhoof, Dup15q Alliance Board Member, Science Committee Co-Chair, and mom to four-year-old Fiona who has Dup15q syndrome. They discussed the role of the Alliance in Clinical Trials and the Importance of Data on Individuals with Dup15q syndrome. "There is a lot of hesitancy on the parent's part in needing to give you medical records. But the most important thing for researchers is that when researchers get the information out it HAS to be deidentified......I promise you that if there is any way that helps parents and sways your fears of putting any information into any of our databases (LADDER Learning Network or Ciitizen). It absolutely comes out deidentified." -Jackie Vanderhoof We continue to reach our goal of $30,000! There is still time to make a gift: https://dup15q.org/2024BG! #Dup15qResearch #LearnTreatCure #Believe #Strategy #ClinicalTrials #Data #DeIdentified #Fundraising #Research 

Pacific Economic Development Canada | Développement économique Canada pour le Pacifique has awarded $5 million to SBME for a new Biodevice Foundry set to launch in our new building in January 2025. A $2.5 million donation from the Conconi Family Foundation helped to unlock the federal grant.    The Biodevice Foundry is a state-of-the-art facility for designing, prototyping, fabricating and testing biodevices that will help accelerate biomedical innovation and grow the life sciences industry to transform health locally and globally.     “The SBME community is thrilled to receive this funding—it will help discover and translate new biodevices that will impact patient health and fuel life sciences industry both locally and globally. We are excited about the new collaborations between industry and academia this facility will support.” Dr. Peter Zandstra.    Explore how the Biodevice Foundry will help impact patient health and bolster Canada’s life sciences and biotech sector.    https://lnkd.in/e76GJ3Jr 

🚀 As we announce a new wave of funding, across research projects in the healthspan space, our CEO Dr Mehmood Khan reflects on Hevolution’s purpose of catalysing the shift from lifespan to healthspan and the mountain we’re committed to climbing as the world's largest philanthropic funder of geroscience: 💡  “We’re spending a decade of life in poor health— this is a decade too many. Our current healthcare system focuses more on intervention, but our goal is to address the underlying causes of aging and age-related diseases. Geroscience and healthspan science are critically underfunded, which is why Hevolution is stepping up to bridge this gap.” ➡️ Learn more about the institutes we’re funding here  https://lnkd.in/gNvjtwnY

Today is World MS Awareness Day 🧡 Today, and every day, we are raising awareness and coming together in solidarity with those affected by Multiple Sclerosis (MS). It is important to develop diagnostic tools and treatments for MS as well as better educate the world and create supportive systems for those with MS. We want to be a part of your journey to helping those with MS by guiding you through the grant application process to achieve non-dilutive funding for the important R&D required to make advancements in MS diagnosis. Don’t wait! Let’s start your non-dilutive funding journey today > https://lnkd.in/dEGv96bG #MultipleSclerosis #MS #Diagnosis #Funding #Grants #LifeSciences #NonDilutiveFunding 

The Human Immunome Project (HIP) seeks a Vice President for Philanthropy to work with the Chief Executive Officer and Board of Directors to maintain and grow HIP's existing portfolio of industry and foundation donors and prospects while building a pipeline of individual major funders. As HIP puts its Scientific Strategic Plan into action, it is seeking a Vice President for Philanthropy to work closely with HIP leaders as they build the resources needed to complete a worldwide health resource that will change the paradigm of global human health. The Human Immunome Project is a global nonprofit organization dedicated to decoding and modeling the immune system. Together with its network of partners, HIP is pioneering the next frontier in health and medicine. HIP envisions a future that harnesses the power of the immune system to improve health for all. The human immune system is one of the most complex systems in the world—and one of its most important. It determines whether we survive infancy, which diseases we get, how we age, and how long we live. Yet its complexity has limited our ability to tap into its potential—until now. HIP was designed to meet this moment—to combine systems biology with the power of artificial intelligence, to decode and model the immune system to improve health for all. "𝘛𝘩𝘦 𝘏𝘶𝘮𝘢𝘯 𝘐𝘮𝘮𝘶𝘯𝘰𝘮𝘦 𝘗𝘳𝘰𝘫𝘦𝘤𝘵 𝘳𝘦𝘱𝘳𝘦𝘴𝘦𝘯𝘵𝘴 𝘰𝘶𝘳 𝘣𝘦𝘴𝘵 𝘴𝘩𝘰𝘵 𝘢𝘵 𝘶𝘯𝘥𝘦𝘳𝘴𝘵𝘢𝘯𝘥𝘪𝘯𝘨 𝘩𝘰𝘸 𝘵𝘩𝘦 𝘩𝘶𝘮𝘢𝘯 𝘪𝘮𝘮𝘶𝘯𝘦 𝘴𝘺𝘴𝘵𝘦𝘮 𝘷𝘢𝘳𝘪𝘦𝘴 𝘱𝘦𝘳𝘴𝘰𝘯 𝘣𝘺 𝘱𝘦𝘳𝘴𝘰𝘯, 𝘵𝘩𝘳𝘰𝘶𝘨𝘩𝘰𝘶𝘵 𝘢 𝘭𝘪𝘧𝘦𝘵𝘪𝘮𝘦, 𝘢𝘯𝘥 𝘢𝘤𝘳𝘰𝘴𝘴 𝘥𝘪𝘧𝘧𝘦𝘳𝘦𝘯𝘵 𝘱𝘰𝘱𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘢𝘳𝘰𝘶𝘯𝘥 𝘵𝘩𝘦 𝘸𝘰𝘳𝘭𝘥, 𝘬𝘯𝘰𝘸𝘭𝘦𝘥𝘨𝘦 𝘵𝘩𝘢𝘵 𝘸𝘪𝘭𝘭 𝘭𝘢𝘺 𝘵𝘩𝘦 𝘧𝘰𝘶𝘯𝘥𝘢𝘵𝘪𝘰𝘯 𝘧𝘰𝘳 𝘱𝘦𝘳𝘴𝘰𝘯𝘢𝘭𝘪𝘻𝘦𝘥 𝘮𝘦𝘥𝘪𝘤𝘪𝘯𝘦. 𝘐 𝘢𝘮 𝘦𝘯𝘦𝘳𝘨𝘪𝘻𝘦𝘥 𝘢𝘵 𝘵𝘩𝘦 𝘱𝘳𝘰𝘴𝘱𝘦𝘤𝘵 𝘰𝘧 𝘮𝘢𝘬𝘪𝘯𝘨 𝘵𝘩𝘢𝘵 𝘢 𝘳𝘦𝘢𝘭𝘪𝘵𝘺 𝘵𝘩𝘳𝘰𝘶𝘨𝘩 𝘏𝘐𝘗, 𝘢𝘯𝘥 𝘥𝘰𝘪𝘯𝘨 𝘴𝘰 𝘪𝘯 𝘢 𝘸𝘢𝘺 𝘵𝘩𝘢𝘵 𝘳𝘦𝘤𝘰𝘨𝘯𝘪𝘻𝘦𝘴 𝘢𝘯𝘥 𝘱𝘶𝘵𝘴 𝘢𝘵 𝘵𝘩𝘦 𝘧𝘰𝘳𝘦𝘧𝘳𝘰𝘯𝘵 𝘵𝘩𝘦 𝘯𝘦𝘦𝘥 𝘰𝘧 𝘢𝘱𝘱𝘭𝘺𝘪𝘯𝘨 𝘥𝘪𝘷𝘦𝘳𝘴𝘪𝘵𝘺, 𝘦𝘲𝘶𝘪𝘵𝘺, 𝘢𝘯𝘥 𝘪𝘯𝘤𝘭𝘶𝘴𝘪𝘰𝘯 𝘪𝘯 𝘰𝘶𝘳 𝘳𝘦𝘴𝘦𝘢𝘳𝘤𝘩 𝘱𝘭𝘢𝘯 𝘢𝘯𝘥 𝘰𝘶𝘳 𝘰𝘳𝘨𝘢𝘯𝘪𝘻𝘢𝘵𝘪𝘰𝘯. 𝘞𝘦 𝘪𝘯𝘷𝘪𝘵𝘦 𝘢𝘱𝘱𝘭𝘪𝘤𝘢𝘵𝘪𝘰𝘯𝘴 𝘧𝘳𝘰𝘮 𝘪𝘯𝘥𝘪𝘷𝘪𝘥𝘶𝘢𝘭𝘴 𝘸𝘩𝘰 𝘩𝘢𝘷𝘦 𝘢𝘯 𝘶𝘯𝘥𝘦𝘳𝘴𝘵𝘢𝘯𝘥𝘪𝘯𝘨 𝘢𝘯𝘥 𝘱𝘢𝘴𝘴𝘪𝘰𝘯 𝘧𝘰𝘳 𝘰𝘶𝘳 𝘮𝘪𝘴𝘴𝘪𝘰𝘯 𝘢𝘯𝘥 𝘢𝘱𝘱𝘳𝘦𝘤𝘪𝘢𝘵𝘦 𝘵𝘩𝘦 𝘶𝘯𝘪𝘲𝘶𝘦 𝘤𝘩𝘢𝘭𝘭𝘦𝘯𝘨𝘦𝘴 𝘢𝘯𝘥 𝘰𝘱𝘱𝘰𝘳𝘵𝘶𝘯𝘪𝘵𝘪𝘦𝘴 𝘢𝘴𝘴𝘰𝘤𝘪𝘢𝘵𝘦𝘥 𝘸𝘪𝘵𝘩 𝘧𝘶𝘯𝘥𝘳𝘢𝘪𝘴𝘪𝘯𝘨 𝘪𝘯 𝘵𝘩𝘦 𝘩𝘦𝘢𝘭𝘵𝘩 𝘱𝘩𝘪𝘭𝘢𝘯𝘵𝘩𝘳𝘰𝘱𝘺 𝘰𝘳 𝘢𝘤𝘢𝘥𝘦𝘮𝘪𝘤 𝘴𝘦𝘵𝘵𝘪𝘯𝘨. 𝘛𝘩𝘢𝘯𝘬 𝘺𝘰𝘶 𝘧𝘰𝘳 𝘺𝘰𝘶𝘳 𝘤𝘰𝘯𝘴𝘪𝘥𝘦𝘳𝘢𝘵𝘪𝘰𝘯!" — Hans Keirstead, 𝗣𝗵.𝗗., 𝗖𝗵𝗶𝗲𝗳 𝗘𝘅𝗲𝗰𝘂𝘁𝗶𝘃𝗲 𝗢𝗳𝗳𝗶𝗰𝗲𝗿 To learn more or apply, visit: https://lnkd.in/etsb7-fV #healthcare #innovation #global #fundraising #hiring

With their recent gift to Mass General, Tianqiao and Chrissy Chen — through their philanthropic organization, the Tianqiao and Chrissy Chen Institute — are recognizing the pivotal role that early- and mid-career investigators play in shaping the future of medicine.   In this video, hear from Tianqiao and Chrissy about their investment in the promising research conducted by some of Mass General Research Institute's most innovative physician-scientists.   Learn more about the Chen Institute's commitment to advancing medical research at Mass General and beyond: https://lnkd.in/ghwjm3qk #MassGeneralGiving

Today, we announced a $2 million investment in research initiatives this year. Because there is still no cure for CF, because the mortality rate is still too high, and because there are still therapeutic gaps, research will continue to be a pillar of our mission. That’s why Cystic Fibrosis Canada is funding projects that align with the priorities of the Canadian CF community, in order to find answers and new solutions. Read the full breakdown of the funded initiatives here: https://bit.ly/3JG1rQF